Viemed Healthcare, Inc. - Common Shares (VMD)
6.7100
+0.0300 (0.45%)
NASDAQ · Last Trade: Sep 28th, 3:46 AM EDT
Detailed Quote
Previous Close | 6.680 |
---|---|
Open | 6.660 |
Bid | 6.540 |
Ask | 6.990 |
Day's Range | 6.570 - 6.715 |
52 Week Range | 5.930 - 9.810 |
Volume | 134,708 |
Market Cap | 265.64M |
PE Ratio (TTM) | 19.17 |
EPS (TTM) | 0.4 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 200,302 |
Chart
About Viemed Healthcare, Inc. - Common Shares (VMD)
Viemed Healthcare Inc is a healthcare company that specializes in providing innovative home healthcare solutions, primarily focusing on the treatment and management of patients with chronic respiratory conditions. The company offers a range of services, including the rental and maintenance of medical equipment such as ventilators and oxygen therapy systems, as well as comprehensive patient care programs aimed at improving health outcomes. By leveraging technology and data analytics, Viemed aims to enhance the quality of care for patients while efficiently managing their healthcare needs within the comfort of their homes. Read More
News & Press Releases
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
Via Benzinga · September 26, 2025
LAFAYETTE, LA / ACCESS Newswire / September 23, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that it has completed all repurchases authorized under its previously announced share repurchase program.
Via ACCESS Newswire · September 23, 2025
LAFAYETTE, LA / ACCESS Newswire / August 6, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced today that it has reported its financial results for the three and six months ended June 30, 2025.
Via ACCESS Newswire · August 6, 2025
LAFAYETTE, LA / ACCESS Newswire / July 22, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, today announced that it will host its Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025, at 11:00 a.m. EDT.
Via ACCESS Newswire · July 22, 2025
LAFAYETTE, LA / ACCESS Newswire / July 2, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has completed the previously disclosed acquisition of Illinois-based Lehan's Medical Equipment ("Lehan") for a base purchase price of $26 million, subject to customary adjustments, plus estimated contingent payments of $2.2 million.
Via ACCESS Newswire · July 2, 2025
Via Benzinga · April 28, 2025

Via Benzinga · January 17, 2025

Via Benzinga · December 27, 2024

Via Benzinga · December 16, 2024

VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024

VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 6, 2024

VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 6, 2024

Here are three small-cap stocks that may be ready to make large moves once volume increases in the markets after Labor Day
Via MarketBeat · August 28, 2023

While consumer prices may be hot, these stocks undervalued stocks to buy under $10 proves you can still catch a bargain.
Via InvestorPlace · August 16, 2023

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.
Via Benzinga · May 8, 2023

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via Benzinga · March 6, 2024

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
Via Benzinga · November 1, 2023